Tamiflu
Indicated to alleviate influenza symptoms and formulated to target virus proliferation.
Strengths: 75mg
Where to Check Availability
Medicine details
- Conditions
- Therapeutic class
Neuraminidase Inhibitor
- Pharmacological class
Neuraminidase Inhibitor
- Contraindications
hypersensitivity to oseltamivir
- Precautions and warnings
monitor for neuropsychiatric events; maintain adequate hydration
- Minor side effects
nausea; vomiting; headache; pain
- Moderate side effects
insomnia; fatigue; dizziness
- Dosage forms
Capsule, hard
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Roche
- Onset Time
24–48 hours
- Duration
5 days
- Storage instructions
Store below 25°C, keep dry.
- Drug interactions
influenza vaccine
- Age restrictions
Use requires age-appropriate dosing.
Serious side effects
anaphylaxis — requires immediate medical attention; Stevens-Johnson syndrome — requires immediate medical attention; toxic epidermal necrolysis — requires immediate medical attention
Patient summary
Indicated to alleviate influenza symptoms and formulated to target virus proliferation.
Mechanism of action
Oseltamivir is a neuraminidase inhibitor that interferes with the release of new viral particles from infected cells, thereby preventing the spread of influenza within the body.
Pregnancy and breastfeeding
Pregnancy: Use only if clinically necessary. Breastfeeding: May be used if clinically necessary.
Tamiflu
Indicated to alleviate influenza symptoms and formulated to target virus proliferation.
Editorial Notes
- Active ingredient(s): Oseltamivir
- Listed indication(s): Influenza
Available option
- 30 tablets - 75 mg1261-75-mg-15076